This content is from: Portfolio A Jim Simons Market Mystery — Solved? A secretive investment fund backed by the legendary quant displays a penchant for biotech stocks. There’s a good reason for that. By Richard Teitelbaum February 07, 2023
Sponsored Aluminum’s Booms and Busts: Is More Volatility Ahead? Sponsored by CME Group December 26, 2022
This content is from: Premium Hedge Fund Backed Databricks Cuts Its Valuation Five high-profile hedge fund firms or their VC arms have made multiple investments in the company. By Stephen Taub October 25, 2022
This content is from: Portfolio The Alts Investments BlackRock’s Avoiding — And the Ones It Can’t Get Enough Of “I do think in private equity, you’ve absolutely seen a shift in sentiment, particularly in the larger end of the market,” says Edwin Conway. By Julie Segal December 12, 2022
This content is from: Premium Tiger Funds Made Big Moves in the Third Quarter Repositioning was the name of the game for D1 Capital, Tiger Global, Lone Pine, Viking, Coatue, and others. By Stephen Taub November 16, 2022
